Home › Oropharyngeal Cancer › Florida › Orlando
Oropharyngeal Cancer clinical trials in Orlando, FL
4 studies for Oropharyngeal Cancer are looking for participants at sites in and around Orlando (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- AdventHealth Orlando, Orlando
A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
RecruitingPhase 1/2
- Florida Cancer Specialists (from Sarah Canon research Institute), Orlando
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
RecruitingPhase 1/2
- Clermont Oncology Center, Clermont · 24 mi away
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
RecruitingPhase 3
- Florida Cancer Specialists and Research Institute, Orlando
Oropharyngeal Cancer trials in other cities
- Chicago, IL9 studies
- Edison, NJ8 studies
- Atlanta, GA7 studies
- New York City, NY7 studies
- St. Louis, MO7 studies
- Omaha, NE7 studies
- Tampa, FL6 studies
- Houston, TX6 studies
- Detroit, MI6 studies
- Baltimore, MD6 studies
- Pittsburgh, PA6 studies
- Los Angeles, CA6 studies
Other studies in Orlando
- Non-Small Cell Lung Cancer47 studies
- Obesity33 studies
- Alzheimer's Disease29 studies
- Metastatic Cancer28 studies
- Overweight27 studies
- Type 2 Diabetes25 studies
- Ovarian Cancer24 studies
- Cancer (all types)24 studies
- Breast Cancer23 studies
- Lung Cancer23 studies
- Ulcerative Colitis21 studies
- Colorectal Cancer21 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.